Lurasidone-Reference-Cited by-同舟云学术

Lurasidone

Published:2012-12-21 Issue:1 Volume:27 Page:67-80
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Sanford Mark

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

http://link.springer.com/content/pdf/10.1007/s40263-012-0026-x.pdf

Reference31 articles.

1. van Os J, Kapur S. Schizophrenia. Lancet. 2009;374(9690):635–45.

2. Kane JM, Correll CU. Past and present progress in the pharmacological treatment of schizophrenia. J Clin Psychiatry. 2010;71(9):1115–24.

3. Jindal RD, Keshavan MS. Classifying antipsychotic agents: need for new terminology. CNS Drugs. 2008;22(12):1047–59.

4. Hopkins CR. ACS chemical neuroscience molecule spotlight on Latuda (lurasidone; SM-13,496). ACS Chem Neurosci. 2011;2(2):58–9.

5. Sunovion Pharmaceuticals Inc. Latuda (lurasidone hydrochloride) tablets, for oral use: US prescribing information. 2012. http://latuda.com/LatudaPrescribingInformation.pdf . Accessed 2012 Sep 12.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta‑analysis of eight short‑term, randomized, double‑blind, placebo‑controlled clinical trials;Biomedical Reports;2024-04-11

2. Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review;Healthcare;2024-01-29

3. Cognitive Effects of Lurasidone and Cariprazine: A Mini Systematic Review;Current Neuropharmacology;2023-12

4. Lurasidone blocks the voltage-gated potassium channels of coronary arterial smooth muscle cells;European Journal of Pharmacology;2023-10

5. Palladium and Iron Cocatalyzed Aerobic Alkene Aminoboration;Journal of the American Chemical Society;2023-08-16